The Latest Breaking News from Cigna

With the rise of chronic diseases, technological advances and innovative drug pipelines are driving significant growth in the healthcare industry. Hence, investors may find long-term stability and exciting opportunities by adding stocks, Johnson & Johnson (JNJ), Pfizer (PFE), and Cigna Group (CI), to their portfolios. Read more….

Cigna Group is set to announce its fiscal third-quarter earnings next week, and analysts anticipate a modest single-digit profit increase.

September Nasdaq 100 E-Mini futures (NQU24) are up +0.36% this morning as strong quarterly results from Meta Platforms and dovish comments from Federal Reserve Chair Jerome Powell boosted sentiment, while investors awaited a new round of U.S. economic data and earnings reports.

Here’s a dividend-paying gem trading at an attractive valuation, which investors can consider this July while it's still a bargain.

Cigna Group is expected to release its fiscal second-quarter earnings next month, and analysts project a single-digit profit increase.

Despite Cigna’s mixed performance relative to the broader S&P 500, Wall Street analysts remain bullish about the stock’s outlook.

Along with regular dividends, these companies all have an impressive track record of solid fundamentals and strong earnings growth forecasts.

UnitedHealth, Humana and other big health insurers fell Monday night on lower-than-expected Medicare Advantage rates for 2025.

There are legal safeguards to protect patients from big bills like out-of-network air-ambulance rides. But insurers may not pay if they decide the ride wasn't medically necessary.